The Relationship Between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease.
作者信息
Byrne Christopher D
机构信息
Professor of Endocrinology and Metabolism Faculty of Medicine University of Southampton Southampton General Hospital Southampton, United Kingdom.
出版信息
Gastroenterol Hepatol (N Y). 2022 Sep;18(9):549-552.
Abstract
摘要
相似文献
1
The Relationship Between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease.
Gastroenterol Hepatol (N Y). 2022 Sep;18(9):549-552.
2
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.
Liver Int. 2019 Feb;39(2):342-352. doi: 10.1111/liv.13992. Epub 2018 Dec 4.
3
CKD and nonalcoholic fatty liver disease.
Am J Kidney Dis. 2014 Oct;64(4):638-52. doi: 10.1053/j.ajkd.2014.05.019. Epub 2014 Jul 30.
4
Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease.
Can J Gastroenterol Hepatol. 2020 Dec 29;2020:6630296. doi: 10.1155/2020/6630296. eCollection 2020.
5
Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood.
World J Gastroenterol. 2021 Sep 14;27(34):5793-5795. doi: 10.3748/wjg.v27.i34.5793.
6
A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C.
Hum Pathol. 2010 Aug;41(8):1178-85. doi: 10.1016/j.humpath.2009.10.025. Epub 2010 Apr 22.
7
The Relationship between Intestinal Motility and Interstitial Cells of Cajal in Nonalcoholic Fatty Liver Mice.
Hepat Mon. 2013 Oct 1;13(10):e13674. doi: 10.5812/hepatmon.13674. eCollection 2013.
8
End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
Hum Pathol. 2010 Mar;41(3):425-30. doi: 10.1016/j.humpath.2009.06.021. Epub 2009 Dec 1.
9
Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
Perit Dial Int. 2016 Jul-Aug;36(4):427-32. doi: 10.3747/pdi.2014.00223. Epub 2015 Oct 16.
10
Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.
Periodontol 2000. 2021 Oct;87(1):204-240. doi: 10.1111/prd.12387.
引用本文的文献
1
Identification of crosstalk genes relating to ECM-receptor interaction genes in MASH and DN using bioinformatics and machine learning.
J Cell Mol Med. 2024 Mar;28(6):e18156. doi: 10.1111/jcmm.18156.
本文引用的文献
1
Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people?
Gut. 2023 Jul;72(7):1238-1239. doi: 10.1136/gutjnl-2022-328316. Epub 2022 Aug 9.
2
Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'.
Diabet Med. 2022 Oct;39(10):e14912. doi: 10.1111/dme.14912. Epub 2022 Jul 20.
3
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review.
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):367-378. doi: 10.1016/S2468-1253(21)00261-2. Epub 2022 Jan 12.
4
Association of metabolic dysfunction-associated fatty liver disease with kidney disease.
Nat Rev Nephrol. 2022 Apr;18(4):259-268. doi: 10.1038/s41581-021-00519-y. Epub 2022 Jan 10.
5
Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications.
Diabetes Obes Metab. 2022 Feb;24 Suppl 2:28-43. doi: 10.1111/dom.14484. Epub 2021 Aug 13.
6
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach.
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):578-588. doi: 10.1016/S2468-1253(21)00020-0. Epub 2021 May 4.
7
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis.
Gut. 2022 Jan;71(1):156-162. doi: 10.1136/gutjnl-2020-323082. Epub 2020 Dec 10.
8
NAFLD as a driver of chronic kidney disease.
J Hepatol. 2020 Apr;72(4):785-801. doi: 10.1016/j.jhep.2020.01.013. Epub 2020 Feb 12.
9
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11.
10
The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Curr Vasc Pharmacol. 2018;16(3):254-268. doi: 10.2174/1570161115666170621081638.
Zotero 插件